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R. S. WELLS, M.D. 
Department of Genetics, The Institute of Dermatology, St . John's Hospital for Diseases of the Skin, London, England 
The development of genetic studies over the last hundred years, in particular as they have 
affected dermatology, has been reviewed. The clinical application of knowledge derived from 
other fields has been emphasized, areas of future research have been indicated, and 
suggestions for cooperation with other disciplines have been offered. 
Every individual, unless he has a monozygotic 
twin, can be distinguished from every other indi-
vidual by his phenotype, that is , his appearance. 
Phenotype results from an interaction between 
environment (including the intrauterine environ-
ment) and genotype , that is, genetic constitution. 
Large numbers of individuals can be racially 
grouped, and it is probably most convenient to 
think about different races as people with different 
sets of genes. A gene is that part of the DNA 
molecule which directs the synthesis of a specific 
polypeptide chain made up of amino acids. A 
mutation is any change in the genetic material 
which results in an abnormal phenotype. 
Advances in the study of genetically determined 
skin disease have been made by two different 
groups of investigators: the true geneticists, that is , 
those who specialize in studying inheritance rather 
than dermatology; and the dermatologists, that is, 
those who have studied a particular genetic skin 
disorder in depth. Although both groups have 
contributed to the subject, it is generally the first 
who have pointed to new horizons of research and 
have shown where a particular type of research will 
be helpful. 
Historically, man must have been as interested 
in his family as in himself and must have observed 
that some diseases occur in brothers and sisters 
and others in parents and their children. Physi-
cians in Arabia and China recorded family diseases 
long before the birth of Western Medicine. A 
typical early "case history" from China describes a 
rickshaw puller who had dry scaly skin "like a 
serpent," and observes that his mother's brother 
was similarly afflicted. This must have been a 
particular type of ichthyosis called X-linked ich-
thyosis. 
Victorian physicians often observed that dis-
eases such as tuberculosis and syphilis were famil-
ial and that some families had a high incidence of 
vagrancy and destitution. The work of Pasteur and 
others made it clear that these disorders were not 
genetic, that is, the "germ seed" was not passed 
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directly from parent to child. Research solved 
many problems but created others. Are some 
families more susceptible to tuberculosis than 
others? Are some races more susceptible to leprosy 
than others? The answers to these and similar 
questions are still controversial and may never be 
definitive because too many variables make exact 
scientific experimentation unfeasible (impossi-
ble?). That there are some individuals with an 
increased susceptibility to disease, e.g., agamma-
globulinemia, is obvious. 
The early illustrated guides to dermatology often 
described the famous Lambert family of "porcu-
pine men" who exhibited themselves all over 
Europe and thus acquainted the populace with an 
excessively rare condition, ichthyosis hystrix grav-
ior. Family studies of these individuals implicated 
a genetic disorder , but the classical description of 
their pedigree-that the disorder is carried on the 
Y chromosome-was wrong. Since the chromosome 
is transmitted by the father, they erroneously 
concluded that all the male children of an affected 
male will have the disorder. Subsequent investiga-
tions , however, showed that ichthyosis hystrix 
gravior is inherited as an autosomal dominant 
condition which affects females as well as males 
and that the Y chromosome does little except 
determine "maleness." Sex-linked disorders can be 
transmitted on the Y as well as on the X chromo-
some, but this term is usually used to imply 
X-linked inheritance. 
In investigative and clinical situations, there-
fore, the first question to be asked is: "Is it genetic 
or not?" Some conditions such as plica polonica 
are so bizarre that it would seem they can only be 
inherited, but actually plica polonica was attrib-
uted to the humid climate in Poland near the 
Pripet Marshes. It is an example of environmental 
factors simulating a genetic disorder. More modern 
examples are the syndromes of chorioretinopathy 
and microcephaly, which can be mimicked by the 
effects of toxoplasmosis and can be clarified by 
tandem studies. 
THE MATTER OF MENDELIAN INHERITANCE 
Modern genetics really began with Gregor Men-
del, who defined what have since become known as 
the Mendelian Laws. His remarkable achieve-
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ments, well-documented in the literature, were 
scarcely known during his lifetime. The rules laid 
down by him are as good today as when he 
formulated them and are particularly relevant to 
the clinical situation. And yet, it is typical of our 
cynical times that statisticians have denigrated his 
experiments from discoveries to mere demonstra-
tions of some of his favorite theories. It has even 
been implied that some of his brother monks 
removed a few peas tC' obtain the answers he 
wanted! 
Two problems of usage which have arisen out of 
his work concern the use of the words dominant 
and recessive. To some people, the word dominant 
when applied to diseases suggests that such dis-
eases are more severe than if they were called 
recessive, whereas usually the reverse is true. If the 
individual has one abnormal gene, the disorder is, 
in fact, due to a dominant gene whereas the 
recessive gene is manifest only if two abnormal 
genes are present. The second difficulty is that 
some individuals have one autosomal recessive 
gene, which may not be clinically manifest. In 
families so identified, a dominant type of pedigree 
can be drawn. A clinically affected individual will 
then be the offspring of a mating between two 
dominant conditions. Since the carriers of reces-
sive genes cannot be identified, such a condition 
seldom gives rise to a difficulty except with some of 
the hemoglobinopathies. Therefore, the terms 
should be retained as Gregor Mendel described 
them. 
According to the studies of Mendel and others, 
single gene (unifactorial) conditions in human 
beings can be inherited by three common modes: 
autosomal dominant, autosomal recessive, and 
X-linked recessive. Other modes of inheritance 
such as X-linked dominant do occur, but they are 
extremely rare. 
The modern disciple of Mendel does not have to 
have a vast knowledge of biochemistry or nuclear 
physics. All that he needs is a patient and the 
energy and funds to visit other members of his or 
her family to determine whether they are or are not 
affected. Using this simple method, he can often 
accurately classify different disorders with a simi-
lar morphology. This point is of fundamental 
importance. Two conditions which look alike but 
have different modes of inheritance cannot be the 
same condition. This follows directly from Men-
del's original observations. 
The man who invented the wheel or the wheel-
barrow or the saddle, or who first painted a white 
line down the middle of a road, has doubtless never 
received his due meed of praise. Likewise, the 
information that can be derived from pedigree 
studies goes back ultimately to Mendel, but the 
first person to apply those data to clinical situa-
tions often remains unknown. A pedigree in only 
one affected person, i.e., a "sporadic case," is not 
helpful to the geneticist. The mode of inheritance 
may be determined by an exact clinical diagnosis 
based on previous experience of large numbers of 
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cases, but the pedigree cannot. If the proband in 
such a pedigree is a male, he could have inherited 
the condition by anyone of the three common 
modes of inheritance mentioned above. 
But when several generations produce affected 
individuals of both sexes, that is when the pedigree 
is a vertical one, then autosomal dominant inheri-
tance is indicated. If, however, only siblings of 
either sex are affected, and, in particular, if 
consanguinity is established or likely, then autoso-
mal recessive inheritance must be presumed. If 
only males manifest the disorder and the condition 
is transmitted through clinically unaffected fe-
males, then it is an example of X-linked inheri-
tance. The most famous pedigree to illustrate this 
mode of inheritance is that of hemophilia, which 
had and still has serious historical implications for 
the crowned heads of Europe. Having unwittingly 
transmitted the gene for hemophilia to many 
people, Queen Victoria was said to have "waged 
biological warfare on the crowned heads of Eu-
rope." There may be some truth in this observation 
because the British throne is one of the very few to 
survive in Europe today. 
Can an X-linked condition occur in females? In 
practical terms, it is most likely to do so in a closed 
community in which an affected male marries a 
female who is a "carrier" for the gene. The affected 
female offspring are clinically affected in the same 
way as the males, that is, they have the same 
appearance and distribution of the lesions. True 
female hemophiliacs, for example, are known to 
exist but are found very rarely. The word carrier is 
currently out of fashion. If it is used at all, it should 
probably refer only to those females who are 
clinically unaffected but who are known to "carry" 
an X-linked gene, for example, to all the daughters 
of a male with an X-linked condition. 
It would be immensely important for genetic 
counselling if females with X-linked conditions, 
that is, "carriers," could be identified. But except 
for occasional pathologies such as anhidrotic ecto-
dermal dysplasia, this remains impossible. The 
Lyon hypothesis that one X chromosome in the 
female is relatively inactive genetically suggests 
that this line of research could be rewarding. 
With regard to autosomal dominant inheritance, 
another term which is out of favor and for good 
reason is "incomplete penetrance" of the gene. 
This phrase has been used so often as a cloak for 
incomplete investigation of the pedigree or the 
individual or to describe an inheritance that is not 
unifactorial but polygenic or multifactorial that it 
is best avoided. It may occasionally be used for a 
single physical sign in a large series of patients, for 
example: "In a series of 100 patients with adenoma 
sebaceum, 34 showed periungual fibromas (pene-
trance was 34%)," but even this is unsatisfactory. 
I have discussed the practical implication of 
Mendel's work in some detail here because I 
believe strongly in two principles. First, people 
who do research in a particular area should try to 
make their work understandable to the physician 
184 WELLS 
SO that it can be of direct value to him when he is 
dealing with patients in his office. If a dermatolo-
gist understands the simple rules of Mendelian 
inheritance, he should be greatly helped when he is 
investigating patients and their families. Unlike 
some other so-called disciplines, where the ground 
rules seem to change every few weeks, these rules 
have not changed for years, not since Mendel first 
enunciated them. Second, I believe that some of 
the genetic mechanisms reported in the literature 
are so complicated that they cannot be true. 
Remember that despite the efforts of some to 
complicate them, the rules of nature are generally 
very simple. 
" INBORN ERRORS OF METABOLISM" 
Although the importance of Alfred B. Garrod's 
contribution to what is now called biochemical 
genetics was not recognized at the time of his study 
of alkaptonuria, he must be acknowledged as the 
next great name in genetics. The number of large 
volumes now devoted to this subject is evidence of 
the advances that have been made since his death 
in 1907 . Perhaps this can best be illustrated by the 
well-known example of phenylketonuria. Although 
this condition is now usually dealt with by pedia-
tricians, the dilution of skin pigment was a most 
important clinical marker and one that might have 
brought the condition within the field of dermatol-
ogy if the cause had not been determined. 
Before its chemical abnormality was elucidated, 
phenylketonuria was first described as a clinical 
syndrome and two steps were taken to halt its 
inroads. Field surveys were made to identify af-
fected children at a very early age and to alert their 
parents to the risks of having other children. Then 
treatment by dietary means was commenced so 
that these individuals, if diagnosed early enough, 
could hope to lead normal lives. This, however, was 
not the end of the matter. New problems arose for 
which new solutions had to be sought. For exam-
ple, it was learned that as these patients (that is, 
the homo zygotes) grow older, they can tolerate a 
higher level of phenylalanine in their blood stream 
which is not harmful to the fully developed central 
nervous system. But, it is harmful to the unborn 
child of a female phenylketonuric and must be 
prevented. 
A recent similar example in dermatology is the 
syndrome acrodermatitis enteropathica, which has 
been shown by Moynahan to be due to a deficiency 
of zinc, that is, to "an inborn error of zinc metab-
olism." Diodoquin proved to be a highly success-
ful treatment for this condition, but it carried 
the risk of blindness. What a choice for a par-
ent to make: a live blind child or a dead child! 
Apparently, however, these patients can be con-
trolled by zinc alone and their genetically deter-
mined biochemical defect, probably resulting from 
an abnormal enzyme, can be easily corrected. 
I shall resist the temptation to cite other exam-
ples, but allow me to make one point very clearly. 
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The historical approach summarized here blasts 
the commonly held, totally negative view that 
nothing can be done to help a patient with a 
genetic disease. More and more conditions become 
amenable to treatment as more and more research 
is done to achieve that end. 
Another point to make is that although this 
group of conditions is extremely rare, it is also 
extremely important. Various terms, such as "na-
ture's sports" or "nature's living experiments," do 
little to remedy the evils or to enhance their 
author's reputation. What is important is that 
affected individuals should be investigated so that 
the knowledge that accrues from such studies can 
be applied to them and to other patients. Phenyl-
ketonuria would not have been solved by studying 
how skin pigment is diluted; acrodermatitis en-
teropathica was not solved by repeated biopsies of 
the skin lesions or for that matter of the bowel 
lesions. These conditions were helped by people 
vigorously trained to draw the correct conclusions 
from observed phenomena. What research could be 
more important than the prevention of mental 
deficiency and death? Anyone of these conditions 
is justification enough for ambitious research pro-
grams. When, for example, will an epidermolysis 
bullosa research group be inaugurated? 
Since a gene-determined enzyme deficiency is 
autosomal recessive, it is likely to be apparent in 
the homozygous state only. In our present state of 
knowledge, these are the problems most likely to 
be unravelled in the near future. Autosomal domi-
nant conditions usually arise from an abnormality 
of a nonenzymic protein, e.g., from a structural 
protein such as collagen which would be difficult to 
elucidate. At the present time it would probably be 
wrong to look for a pure enzyme deficiency in an 
autosomal dominant disorder. 
SPLITTERS OR LUMPERS 
For geneticists this controversy has been over for 
many years now. There can be little doubt that we 
must all be splitters, when dealing with genetic 
disorders, because all the evidence points that way. 
Albinism, the Ehlers-Danlos syndrome, ichthyo-
sis, and numerous other examples can be cited. 
It may be possible in the future to teach derma-
tology from the cell outwards, but I do not think 
that we are anywhere near that desideratum yet. 
However, with the unravelling of the structure of 
DNA by Watson and Crick, we now know that 
genetic information is stored within the DNA 
molecule in the form of a code. The basis of this 
genetic code is the fact that the primary action of 
the gene is to synthesize protein and that different 
genes are due to different arrangements of amino 
acids within the DNA molecule. However, there is 
one area, the hemoglobins, where present knowl-
edge is at or near a molecular level. There are four 
main types of hemoglobin: A, A2, fetal, and 
embryonic. Hemoglobin A consists of two alpha 
and two beta polypeptide chains. Even very local-
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ized changes in one chain can produce profound 
differences in the phenotype, that is, in the clinical 
expression of the disease. It will probably be many 
years before the study of other diseases reaches this 
advanced state. 
The role of the gene in determining the amino 
acid sequence of a protein was discovered in 1957 
by Vernon Ingram, who studied the difference 
between hemoglobin A and sickle hemoglobin. 
Sickle-cell anemia is a particularly instructive 
disease for many reasons. The difference between 
normal and sickle-cell hemoglobin lies in the beta 
chain and involves only one of the 146 amino acids 
in the chain, yet this results in a disease which can 
be fatal in the homozygous state. The substitution 
of valine for glutamic acid in the beta chain causes 
clinical symptoms which affect the central nervous 
system, the cardiovascular and alimentary sys-
tems, and the kidneys. It has persisted because 
it confers some heterozygote advantage in malarial 
areas. In the United States, where it no longer 
confers such advantage, it is gradually disappear-
ing. Because of studies like these, the well-known 
phrase, "one gene-one enzyme," has been 
changed to "one gene-one polypeptide." 
McKusick, in his catalogue of single gene condi-
tions, lists nearly 2,000 conditions for which the 
mode of inheritance is known or very likely to be 
known, but he emphasizes that this total , large as 
it seems, is very small compared with the total 
number of genes, which is probably not less than 
100,000. These figures give some idea of the com-
plexity of the problem and the work that needs to 
be done, even in a speciality such as dermatology. 
OTHER ASPECTS 
With very few exceptions, all the great advances 
in the study of human genetics have been made in 
this century, although the twin method was first 
developed by Galton at the end of the last century. 
This is still used to distinguish genetic from 
nongenetic disorders. In 1908, Hardy and Weinberg 
focused attention on gene frequencies in popula-
tions. In 1934, Thomas Hunt Morgan was awarded 
the Nobel prize for his work on the nature of the 
gene and in 1946 Herman Muller won a similar 
prize for the discovery of the induction of ne~ 
mutations by x-ray. 
Although Cockayne's work, published in 1933, 
'was not so important, it was a milestone for both 
-lermatology and clinical genetics. It was the first 
;)Ublished book to be devoted specifically to ge-
letic disorders in one speciality and has been 
mitated many times since then in many subjects. 
: ~ ockayne was interested in a comparative ap-
)roach to the genetic aspects of butterflies, and 
nany people since have followed his lead and 
.dapted the same approach to human genetics. 
Chis comparative aspect is often neglected by 
nodern dermatologists who have a great deal to 
earn from veterinary science with regard to genetic 
l isorders in particular and skin diseases in general. 
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Because of the influence of Francis Galton and 
Karl Pearson, and, later on, R. A. Fisher, J. B. S. 
Haldane, Sewell Wright, and L. S. Penrose, genet-
ics has been associated in many people's minds 
with extremely complicated mathematics. It is, 
therefore, not surprising that in a scientific subject 
like genetics, mathematics should have been used 
for the study of segregation analysis, linkage stud-
ies, and the estimation of mutation rates . Such 
studies are for the experts, but dermatologists can 
contribute the clinical aspects, that is, can provide 
the raw material for research. 
Linkage Studies. 
Owing to the work on the fruit fly, Drosophila, it 
became evident that two genes can be "linked," 
that is, if they are sufficiently close to each other, 
something less than a completely independent 
assortment can take place. From this, the loci of 
genes on the chromosomes of some species can be 
mapped with great accuracy, but in man this 
information is in its very early stages. The only 
chromosome for which anything like the begin-
nings of a "map" can be drawn is the X chromo-
some. Two dermatologic conditions, angiokera-
toma corporis diffusum (Fabry's disease) and 
X-linked ichthyosis, exemplify this linkage. With 
the possibility of very exact diagnosis, it would 
seem that dermatology can play an increasingly 
important part in the future with this very basic 
scientific work. 
Cytogenetics. 
In 1959, Lejeune and his co-workers reported 
that a chromosomal aberration is the cause of 
Mongolism (Down's syndrome). Since then, the 
work on human chromosomal abnormalities has 
proliferated. The causes of many obscure condi-
tions have been identified and are generally found 
to be very gross abnormalities of the chromosomes. 
The abnormality responsible for a condition such 
as Darier's disease is a point mutation, that is, the 
abnormal gene is located at a single point on one of 
the 22 autosomal chromosomes. Such a point 
cannot be visualized by any of the techniques 
currently available. There is no reason to ask for 
chromosomal analysis, a time-consuming task, for 
conditions where the mode of inheritance is known 
to be that of a single gene. In fact. lists are 
available of most of the genodermatcses v.here 
chromosomal analysis has been carried out and 
found to be normal. 
MULTIFACTORIAL (POLYGENIC) INHERITANCE 
The incidence of a single gene condition is less 
than 1 in 1,000 of the population, but the com-
monly occurring disorders with a genetic compo-
nent in their etiology have a population frequency 
greater than that. Examples in dermatology are 
probably psoriasis and atopic eczema and even 
vitiligo and acne vulgaris; in the etiology of these 
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conditions, environmental factors play a most 
important part. 
These disorders are inherited by a multiple-gene 
system, the characteristic features of which have 
been recognized only comparatively recently. In 
general, single-gene conditions are classified as 
high-risk conditions, whereas multifactorial condi-
tions are said to be low risk because the probability 
of a recurrence in a family with one affected child 
is 5% or less. However, in a family with two 
affected individuals the risk will be increased. 
These conditions are said to be due to many 
genes, each with a small but additive effect. A 
point on a Gaussian distribution curve above 
which all individuals are affected is called the 
threshold for the condition. Normal variation in 
the population, for example, height and intelli-
gence, are thought to be inherited by such systems. 
GENETIC COUNSELLING 
Genetic counselling is playing an increasing role 
in the work of the clinical geneticist. The lifetime 
cost of maintaining one seriously defective individ-
ual on an average can be as much as a quarter of a 
million dollars , sufficient justification for increas-
ing the funds allocated to this type of research. It 
costs approximately $17,000 to detect each case of 
phenylketonuria. In the first ten years of life 
dietetic treatment to prevent brain damage can 
cost about $10,000, that is, a cost of approximately 
$30,000 per child. Untreated, severely retarded 
phenylketonurics living for about 50 years would 
cost $300,000. From this, it will be seen that the 
cost of missing a case , or giving wrong genetic 
advice, can be enormous. 
There is no reason why every physician should 
not be able to give accurate genetic counselling in 
his own office; it is the responsibility of doctors 
with a special research interest to provide him with 
the information to do so. However, it must be 
accurate, and that totally depends on a correct 
diagnosis and knowledge of the mode of inheri-
tance. Such have been the advances in the last 25 
years , that accurate estimates can be given within 
the limits of the three chief methods of inheritance, 
that is , single gene, multifactorial (polygenic), and 
chromosomal. 
The objectives of genetic counselling are to 
answer parents ' questions, to warn doctors of 
special risks with a particular child, and to try to 
lessen the frequency of genetically determined 
disorders. To achieve these objectives, a new area 
of investigation has been developed, that is , an-
tenatal diagnosis. For example, after the birth of 
one child with xeroderma pigmentosum, subse-
quent affected children can be diagnosed in utero. 
FUTURE PERSPECTIVE IN GENODERMATOLOGY 
The work yet to be done is so great that the prob-
lem is where to begin, rather than what to do. As 
long as one skin disorder remains with a genetic 
etiology whose mode of inheritance is not known, 
research must continue in the following areas. 
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1. Pedigree investigations, twin studies, and 
other in-depth studies of inbred communities must 
be done to determine a genetic etiology for skin 
conditions. 
2. Phenotypes and their mode of inheritance 
must be identified. 
3. "Carrier" females with X-linked conditions 
that are not manifest must be identified. In many 
disorders, some females have the abnormal gene so 
that this problem should not be too difficult. The 
main applications are in accurate genetic coun-
selling. 
4. Much more research is needed into those con-
ditions for which an autosomal recessive mode of 
inheritance has been established, that is, those with 
a probable enzymic defect. They are the easiest to 
study and the most likely to be solved; moreover 
they lend themselves to treatment after the genetic 
abnormality has been determined. Examples for 
research include epidermolysis bullosa, ichthyosis, 
and some forms of chronic mucocutaneous can-
didiasis. Since these conditions are uncommon, 
drug companies lack the financial incentive to 
study them. Therefore, university departments of 
dermatology will have to fill the gap. 
5. Autosomal recessive conditions in the new-
born usually indicate an abnormal child. The num-
ber of serious conditions that can now be diagnosed 
before birth is increasing every year. 
6. No other form of basic research has a better 
scientific validity than a definition of the genotype. 
Chromosome mapping, in particular mapping of 
the X chromosome, is a fundamental approach 
to genetic problems which opens up vistas for 
genetic engineering. 
7. Cooperation with specialists in other fields is 
a necessity. Geneticists, pediatricians, immunolo-
gists, and tissue culture experts can all contribute 
to a more accurate diagnosis. Data can be provided 
by dermatologists for studies of gene frequency and 
mutation rates. The development of genetics is one 
of the striking examples of interaction between 
different disciplines which doubtless will continue. 
8. More and better research should result in 
better genetic counselling and this should help to 
improve the quality of human life. 
9. Research into the therapy of genetic disor-
ders should be expanded. It can be if a positive 
attitude is adopted. 
Each of these nine areas could command the 
time and talent of many individuals for a lifetime. 
I hope that my emphasis on the importance of 
genetic research has pointed out the general di-
rection such research should take. 
BIBLIOGRAPHY 
The topics discussed in this review are described in 
greater detail in the following publications: 
Boyer SH: Papers on Human Genetics. Englewood Cliffs, 
NJ, Prentice-Hall, 1963 
Ford CE, Harris HA (eds): New aspects of human genet-
ics. A series of papers on human genetics. Br Med 
Bull 25: 
July 1976 
Emery AE: Modern Trends in Human Genetics. London, 
Butterworths, 1970 
Garrod AE: Inborn Errors of Metabolism. London, Ox-
ford University Press, 1908 
Ingram VM: Gene mutations in human haemoglobin: the 
chemical difference between normal and sickle-cell 
haemoglobin. Nature (Lond) 180:372-000, 1957 
Lejeune J, Gautier M, Turpin R: Etude des chromo-
somes somatique de neuf enfants mongoliens. CR 
Acad Sci[D] (Paris) 248:1721-000,1959 
Lyon MF: Gene action in the X-chromosome of the 
GENETICS AND DERMATOLOGY 187 
mouse. Nature (Lond) 190:372-000, 1961 
McKusick VA: Mendelian Inheritance in Man. Catalogs 
of Autosomal Dominant, Autosomal Recessive and X-
Linked Phenotypes. Third edition. Baltimore, Johns 
Hopkins Press, 1971 . 
Sorsby A: Gregor Mendel. Br Med J 1:333-000, 1965 
Srb AM, Owen RD, Edgar RS: General Genetics. Sec-
ond edition. San Francisco, London, WH Freeman, 
1965 
Sturtevant AH: A History of Genetics. New York, Harper 
& Row, 1965 
